Hainan Novozan exits Logilet (UK) Limited with 65% stake transferred
Published
Hainan Novozan Biotechnology exited Logilet (UK) Limited, a point-of-care DNA diagnostics firm, transferring its 65% ordinary holding. The filing does not name the recipient.
Xiamen Judi Gongying Enterprise Management Partnership (Limited Partnership) entered with a 3.8% preference holding.
Andon Hong Kong Co., Limited entered with a 3.5% preference holding.
Nanjing Zijin Biomedical Industry Investment Fund Partnership (Limited Partnership) entered with a 2.5% preference holding.
Huaxi Yinfeng Investment Co., Limited entered with a 2.5% preference holding.
The four new non-individual holders and larger register suggest fresh funding. Filed on 20 September 2026, covering 13 August to 20 September 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| Exited | HAINAN NOVOZAN BIOTECHNOLOGY CO., LTD. | 0 | — | ORD 0 |
| New shareholder | XIAMEN JUDI GONGYING ENTERPRISE MANAGEMENT PARTNERSHIP (LIMITED PARTNERSHIP) | 46,247 | — | PREFERENCE 46,247 |
| New shareholder | ANDON HONG KONG CO., LIMITED | 43,243 | — | PREFERENCE 43,243 |
| New shareholder | HUAXI YINFENG INVESTMENT CO., LIMITED | 30,831 | — | PREFERENCE 30,831 |
| New shareholder | NANJING ZIJIN BIOMEDICAL INDUSTRY INVESTMENT FUND PARTNERSHIP (LIMITED PARTNERSHIP) | 30,831 | — | PREFERENCE 30,831 |
Current shareholders (7)
| Shareholder | Total shares | Share classes |
|---|---|---|
| HAINAN VAZYME BIOTECH CO., LTD. | 701,415 | ORD 701,415 |
| NEWRGY CAPITAL LIMITED | 269,775 | ORD 269,775 |
| HONOR CAPITAL LIMITED | 107,910 | ORD 107,910 |
| XIAMEN JUDI GONGYING ENTERPRISE MANAGEMENT PARTNERSHIP (LIMITED PARTNERSHIP) | 46,247 | PREFERENCE 46,247 |
| ANDON HONG KONG CO., LIMITED | 43,243 | PREFERENCE 43,243 |
| NANJING ZIJIN BIOMEDICAL INDUSTRY INVESTMENT FUND PARTNERSHIP (LIMITED PARTNERSHIP) | 30,831 | PREFERENCE 30,831 |
| HUAXI YINFENG INVESTMENT CO., LIMITED | 30,831 | PREFERENCE 30,831 |
Similar companies
Companies with the most similar business descriptions.
- Biofab Innovations LtdDiagnostics · MedTech · Biotech
- Genetree LimitedDiagnostics · Biotech · Genomics
- Biofab Technology LimitedDiagnostics · MedTech
- Camtech Innovations LimitedLab Tech · Diagnostics · Biotech
- Biofab LtdHardware · Health Tech · Medical Devices
- Genetic Signatures (Uk) LimitedDiagnostics · Biotech · Lab Tech
More rounds like this
Contact the editorial team at editorial@fundingspotter.com